Personalized and long-term electronic informed consent in clinical research: stakeholder views

[1]  P. Valcke,et al.  Conducting Non-COVID-19 Clinical Trials during the Pandemic: Can Today's Learning Impact Framework Efficiency? , 2020, European journal of health law.

[2]  I. Huys,et al.  Implementation of Electronic Informed Consent in Biomedical Research and Stakeholders’ Perspectives: Systematic Review , 2020, Journal of medical Internet research.

[3]  K. Nilsson,et al.  Patients’ reasoning regarding the decision to participate in clinical cancer trials: an interview study , 2018, Trials.

[4]  Michael Goldsmith,et al.  Wider Research Applications of Dynamic Consent , 2018, Privacy and Identity Management.

[5]  S. R. Ramos,et al.  User-Centered Design, Experience, and Usability of an Electronic Consent User Interface to Facilitate Informed Decision-Making in an HIV Clinic , 2017, Computers, informatics, nursing : CIN.

[6]  R. Kadam Informed consent process: A step further towards making it meaningful! , 2017, Perspectives in clinical research.

[7]  S. Beck,et al.  Dynamic Consent: a potential solution to some of the challenges of modern biomedical research , 2017, BMC Medical Ethics.

[8]  J. Perlmutter,et al.  Paving the way to a more effective informed consent process: Recommendations from the Clinical Trials Transformation Initiative. , 2016, Contemporary clinical trials.

[9]  Ellen Uiters,et al.  Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU) , 2015, European journal of public health.

[10]  Michael Morrison,et al.  Dynamic consent: a patient interface for twenty-first century research networks , 2014, European Journal of Human Genetics.

[11]  N. Gale,et al.  Using the framework method for the analysis of qualitative data in multi-disciplinary health research , 2013, BMC Medical Research Methodology.

[12]  Adam A. Nishimura,et al.  Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials , 2013, BMC medical ethics.

[13]  V. Entwistle,et al.  Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision , 2012, Journal of Medical Ethics.

[14]  D. Resnik,et al.  Participants’ responsibilities in clinical research , 2012, Journal of Medical Ethics.

[15]  Matthew E Falagas,et al.  Informed consent: how much and what do patients understand? , 2009, American journal of surgery.

[16]  P. Sainsbury,et al.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. , 2007, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[17]  V. Jenkins,et al.  Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy , 2000, British Journal of Cancer.

[18]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..